Lee's Pharmaceutical Holdings Ltd
HKEX:950
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| HK |
|
Lee's Pharmaceutical Holdings Ltd
HKEX:950
|
871.5m HKD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
965.7B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
594B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
291.5B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236.4B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
242.5B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
303.7B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
152.2B USD |
Loading...
|
|
| UK |
|
GSK plc
XETRA:GS71
|
105.9B EUR |
Loading...
|
Market Distribution
| Min | -3 900% |
| 30th Percentile | 12.5% |
| Median | 26.6% |
| 70th Percentile | 42.7% |
| Max | 905% |
Other Profitability Ratios
Lee's Pharmaceutical Holdings Ltd
Glance View
Lee's Pharmaceutical Holdings Ltd. engages in the development, manufacture and sale of pharmaceutical products. The firm operates through two segments. Proprietary Products segment is engaged in the manufacture and sales of self-developed pharmaceutical products. Its proprietary products include Yallaferon, Livaracine and Slounase, among others. Licensed-in Products segment is engaged in the trading of licensed-in pharmaceutical products. Its licensed-in products include Ferplex and Zanidip, among others. The Company’s products are for cardiovascular and infectious diseases, dermatology, oncology, gynecology and ophthalmology, among others. The firm mainly operates businesses in China and Hong Kong.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Lee's Pharmaceutical Holdings Ltd is 53.1%, which is below its 3-year median of 53.8%.
Over the last 3 years, Lee's Pharmaceutical Holdings Ltd’s Gross Margin has decreased from 63% to 53.1%. During this period, it reached a low of 51.5% on Jun 30, 2024 and a high of 63% on May 30, 2022.
